Clinical Study

Differential Diagnosis between Low-Grade and High-Grade Astrocytoma Using System A Amino Acid Transport PET Imaging with C-11-MeAIB: A Comparison Study with C-11-Methionine PET Imaging

Table 2

SUVmax and T/N ratios of MeAIB- and MET-PET study in patients with brain tumors.

Group A (benign group)
DiagnosisMeAIBMET
SUVmaxT/N ratioSUVmaxT/N ratio

1Low-grade glioma0.583.221.981.78
2Astrocytoma grade II2.838.092.831.35
3Low-grade glioma0.241.641.801.04
4Glioma grade II0.151.253.032.37
5Low-grade glioma0.621.113.131.82
6Low-grade glioma0.852.073.892.54
7Brain stem glioma3.404.863.031.89
8Glioma grade II, rec.3.496.131.962.68
9Low-grade glioma0.324.004.824.38
10Low-grade glioma0.46.672.193.22
11Low-grade glioma1.344.964.086.07
12Low-grade glioma0.121.203.412.54
Ave.ā€‰1.203.773.012.64

Group B (malignant group)
13GBM4.8132.075.824.44
14GBM, rec.2.9514.893.493.45
15GBM, rec.2.9426.723.633.67
16GBM, rec.2.338.965.392.51
17GBM, rec.2.8412.915.542.55
18GBM, rec.2.8315.004.273.30
19GBM1.604.003.101.24
20GBM2.8922.236.473.87
21GBM, rec.4.5125.106.143.23
22GBM, rec.2.8917.003.402.91
23GBM2.8117.566.076.07
24GBM5.8515.814.573.41
25GBM, rec.1.2217.431.461.76
26GBM, rec.4.5821.735.902.71
27GBM, rec.2.8315.004.273.30
28GBM2.8922.237.824.68
29Anaplastic astrocytoma1.9510.265.944.01
30Anaplastic astrocytoma1.737.862.181.79
31GBM1.4313.004.272.12
Ave.ā€‰2.9416.834.723.21